Status:
COMPLETED
Study of CIDP Patients During IVIG Treatment
Lead Sponsor:
University of Aarhus
Conditions:
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Eligibility:
All Genders
18-80 years
Brief Summary
The aim of this study is to quantify the effect of IVIG treatment in a group of patients with chronic inflammatory demyelinating polyradiculoneuropathy(CIDP), who requires continues treatment of IVIG ...
Detailed Description
Background: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare autoimmune disease of the peripheral nervous system characterized by demyelination of the nerves, which causes mu...
Eligibility Criteria
Inclusion
- Motor and sensory dysfunction involving more than one limb.
- Electrodiagnostic study with signs of demyelination
Exclusion
- Prior systemic allergic reaction to IVIG
- Severe systemic disease
- Other conditions associated with neuropathy (eg diabetes, lack of vitamin- B12)
- Pregnancy
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00305266
Start Date
August 1 2005
End Date
August 1 2007
Last Update
December 3 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital, Department of Neurology
Aarhus, Denmark